Literature DB >> 22154068

Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia.

David A Lewis1, Allison A Curley, Jill R Glausier, David W Volk.   

Abstract

Deficits in cognitive control, a core disturbance of schizophrenia, appear to emerge from impaired prefrontal gamma oscillations. Cortical gamma oscillations require strong inhibitory inputs to pyramidal neurons from the parvalbumin basket cell (PVBC) class of GABAergic neurons. Recent findings indicate that schizophrenia is associated with multiple pre- and postsynaptic abnormalities in PVBCs, each of which weakens their inhibitory control of pyramidal cells. These findings suggest a new model of cortical dysfunction in schizophrenia in which PVBC inhibition is decreased to compensate for an upstream deficit in pyramidal cell excitation. This compensation is thought to rebalance cortical excitation and inhibition, but at a level insufficient to generate the gamma oscillation power required for high levels of cognitive control.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22154068      PMCID: PMC3253230          DOI: 10.1016/j.tins.2011.10.004

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  118 in total

1.  Postnatal differentiation of basket cells from slow to fast signaling devices.

Authors:  Daniel Doischer; Jonas Aurel Hosp; Yuchio Yanagawa; Kunihiko Obata; Peter Jonas; Imre Vida; Marlene Bartos
Journal:  J Neurosci       Date:  2008-11-26       Impact factor: 6.167

Review 2.  Cellular basis of working memory.

Authors:  P S Goldman-Rakic
Journal:  Neuron       Date:  1995-03       Impact factor: 17.173

3.  Synaptogenesis in the prefrontal cortex of rhesus monkeys.

Authors:  J P Bourgeois; P S Goldman-Rakic; P Rakic
Journal:  Cereb Cortex       Date:  1994 Jan-Feb       Impact factor: 5.357

4.  Reducing prefrontal gamma-aminobutyric acid activity induces cognitive, behavioral, and dopaminergic abnormalities that resemble schizophrenia.

Authors:  Takeshi Enomoto; Maric T Tse; Stan B Floresco
Journal:  Biol Psychiatry       Date:  2010-12-10       Impact factor: 13.382

5.  Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia.

Authors:  Takanori Hashimoto; H Holly Bazmi; Karoly Mirnics; Qiang Wu; Allan R Sampson; David A Lewis
Journal:  Am J Psychiatry       Date:  2008-02-15       Impact factor: 18.112

Review 6.  GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia.

Authors:  Guillermo Gonzalez-Burgos; David A Lewis
Journal:  Schizophr Bull       Date:  2008-06-26       Impact factor: 9.306

7.  Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjects.

Authors:  W Gordon Frankle; Raymond Y Cho; Rajesh Narendran; N Scott Mason; Shivangi Vora; Maralee Litschge; Julie C Price; David A Lewis; Chester A Mathis
Journal:  Neuropsychopharmacology       Date:  2008-07-09       Impact factor: 7.853

8.  Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and stimulates others.

Authors:  Miranda A Karson; Kevin C Whittington; Bradley E Alger
Journal:  Neuropharmacology       Date:  2007-07-01       Impact factor: 5.250

9.  Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study.

Authors:  Naoki Goto; Reiji Yoshimura; Junji Moriya; Shingo Kakeda; Nobuhisa Ueda; Atsuko Ikenouchi-Sugita; Wakako Umene-Nakano; Kenji Hayashi; Norihiro Oonari; Yukunori Korogi; Jun Nakamura
Journal:  Schizophr Res       Date:  2009-05-21       Impact factor: 4.939

10.  Prefrontal GABA(A) receptor alpha-subunit expression in normal postnatal human development and schizophrenia.

Authors:  Carlotta E Duncan; Maree J Webster; Debora A Rothmond; Sabine Bahn; Michael Elashoff; Cynthia Shannon Weickert
Journal:  J Psychiatr Res       Date:  2010-01-25       Impact factor: 4.791

View more
  442 in total

1.  Severe cross-modal object recognition deficits in rats treated sub-chronically with NMDA receptor antagonists are reversed by systemic nicotine: implications for abnormal multisensory integration in schizophrenia.

Authors:  Derek L Jacklin; Amit Goel; Kyle J Clementino; Alexander W M Hall; John C Talpos; Boyer D Winters
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

Review 2.  Psychiatric drugs bind to classical targets within early exocytotic pathways: therapeutic effects.

Authors:  Henry A Lester; Julie M Miwa; Rahul Srinivasan
Journal:  Biol Psychiatry       Date:  2012-07-06       Impact factor: 13.382

3.  α2-containing GABA(A) receptors: a requirement for midazolam-escalated aggression and social approach in mice.

Authors:  Emily L Newman; Kiersten S Smith; Aki Takahashi; Adam Chu; Lara S Hwa; Yang Chen; Joseph F DeBold; Uwe Rudolph; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2015-09-17       Impact factor: 4.530

4.  Cortical synaptic NMDA receptor deficits in α7 nicotinic acetylcholine receptor gene deletion models: implications for neuropsychiatric diseases.

Authors:  Hong Lin; Fu-Chun Hsu; Bailey H Baumann; Douglas A Coulter; David R Lynch
Journal:  Neurobiol Dis       Date:  2013-12-08       Impact factor: 5.996

5.  Efficient Generation of CA3 Neurons from Human Pluripotent Stem Cells Enables Modeling of Hippocampal Connectivity In Vitro.

Authors:  Anindita Sarkar; Arianna Mei; Apua C M Paquola; Shani Stern; Cedric Bardy; Jason R Klug; Stacy Kim; Neda Neshat; Hyung Joon Kim; Manching Ku; Maxim N Shokhirev; David H Adamowicz; Maria C Marchetto; Roberto Jappelli; Jennifer A Erwin; Krishnan Padmanabhan; Matthew Shtrahman; Xin Jin; Fred H Gage
Journal:  Cell Stem Cell       Date:  2018-05-03       Impact factor: 24.633

6.  Cognitive ability is associated with altered medial frontal cortical circuits in the LgDel mouse model of 22q11.2DS.

Authors:  D W Meechan; H L H Rutz; M S Fralish; T M Maynard; L A Rothblat; A-S LaMantia
Journal:  Cereb Cortex       Date:  2013-11-11       Impact factor: 5.357

7.  Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects.

Authors:  J R Glausier; K N Fish; D A Lewis
Journal:  Mol Psychiatry       Date:  2013-11-12       Impact factor: 15.992

Review 8.  Neuroimaging biomarkers for early drug development in schizophrenia.

Authors:  Jason R Tregellas
Journal:  Biol Psychiatry       Date:  2013-10-04       Impact factor: 13.382

Review 9.  The chandelier cell, form and function.

Authors:  Melis Inan; Stewart A Anderson
Journal:  Curr Opin Neurobiol       Date:  2014-02-18       Impact factor: 6.627

10.  Altered Expression of ARP2/3 Complex Signaling Pathway Genes in Prefrontal Layer 3 Pyramidal Cells in Schizophrenia.

Authors:  Dibyadeep Datta; Dominique Arion; Kaitlyn M Roman; David W Volk; David A Lewis
Journal:  Am J Psychiatry       Date:  2016-08-13       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.